TW201311B - - Google Patents

Download PDF

Info

Publication number
TW201311B
TW201311B TW081103807A TW81103807A TW201311B TW 201311 B TW201311 B TW 201311B TW 081103807 A TW081103807 A TW 081103807A TW 81103807 A TW81103807 A TW 81103807A TW 201311 B TW201311 B TW 201311B
Authority
TW
Taiwan
Prior art keywords
benzodiazepine
triazole
imidazole
fluoro
patent application
Prior art date
Application number
TW081103807A
Other languages
English (en)
Chinese (zh)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of TW201311B publication Critical patent/TW201311B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
TW081103807A 1991-06-17 1992-05-15 TW201311B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH179191 1991-06-17
CH114092 1992-04-08

Publications (1)

Publication Number Publication Date
TW201311B true TW201311B (cg-RX-API-DMAC7.html) 1993-03-01

Family

ID=25686778

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081103807A TW201311B (cg-RX-API-DMAC7.html) 1991-06-17 1992-05-15

Country Status (15)

Country Link
US (1) US5387585A (cg-RX-API-DMAC7.html)
EP (1) EP0519307A3 (cg-RX-API-DMAC7.html)
JP (1) JPH078869B2 (cg-RX-API-DMAC7.html)
KR (1) KR930000517A (cg-RX-API-DMAC7.html)
AU (1) AU655472B2 (cg-RX-API-DMAC7.html)
CA (1) CA2069382A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ185092A3 (cg-RX-API-DMAC7.html)
FI (1) FI922827A7 (cg-RX-API-DMAC7.html)
HU (1) HU9201929D0 (cg-RX-API-DMAC7.html)
IE (1) IE921945A1 (cg-RX-API-DMAC7.html)
IL (1) IL102175A0 (cg-RX-API-DMAC7.html)
IS (1) IS3878A (cg-RX-API-DMAC7.html)
NO (1) NO922367L (cg-RX-API-DMAC7.html)
NZ (1) NZ243091A (cg-RX-API-DMAC7.html)
TW (1) TW201311B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
JPH10298078A (ja) * 1997-05-06 1998-11-10 Mitsubishi Chem Corp 抗不安薬
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
HU230352B1 (hu) * 2001-06-12 2016-02-29 Wellstat Therapeutics Corporation Metabolikus rendellenességek kezelésére adható vegyületek és ezeket tartalmazó gyógyászati készítmények
AU2005293820B2 (en) 2004-10-12 2010-11-25 F. Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
CA2584259C (en) * 2004-10-20 2013-04-02 F. Hoffmann-La Roche Ag Imidazo-benzodiazepine derivatives
EP1828194B1 (en) 2004-12-14 2008-05-28 F. Hoffmann-Roche AG Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
BRPI0617204A2 (pt) 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
AU2014240289B2 (en) * 2008-09-23 2015-12-03 The Johns Hopkins University Fused diimidazodiazepine compounds and methods of use and manufacture thereof
CA2738650C (en) 2008-09-23 2017-07-04 Johns Hopkins University Fused diimidazodiazepine compounds and methods of use and manufacture thereof
US9322831B2 (en) 2008-09-23 2016-04-26 The Johns Hopkins University DDX3 as a biomarker for cancer and methods related thereto
CA2818025A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
HUE048874T2 (hu) 2013-09-06 2020-08-28 Aurigene Discovery Tech Ltd 1,2,4-oxadiazol-származékok, mint immunmodulátorok
EP4032889A1 (en) * 2013-12-20 2022-07-27 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA2979161A1 (en) * 2015-03-10 2016-09-15 Aurigene Discovery Technologies Limited 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
AU2016230793B2 (en) 2015-03-10 2021-03-25 Aurigene Discovery Technologies Limited 1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
CA2990004C (en) 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA3008171A1 (en) 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio, Inc. derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
WO2018237084A1 (en) 2017-06-21 2018-12-27 SHY Therapeutics LLC COMPOUNDS INTERACTING WITH RAS SUPERFAMIL FOR USE IN THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES AND FIBROTIC DISEASES
WO2019061324A1 (en) 2017-09-29 2019-04-04 Curis Inc. CRYSTALLINE FORMS OF IMMUNOMODULATORS
EP3694841A1 (en) 2017-10-11 2020-08-19 Aurigene Discovery Technologies Limited Crystalline forms of 3-substituted 1,2,4-oxadiazole
MX2020004531A (es) 2017-11-03 2020-08-03 Aurigene Discovery Tech Ltd Inhibidores dobles de tim-3 y las vias de pd-1.
EP3706798A1 (en) 2017-11-06 2020-09-16 Aurigene Discovery Technologies Limited Conjoint therapies for immunomodulation
AU2019288382B2 (en) 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP7407461B2 (ja) 2018-12-19 2024-01-04 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
ATE110726T1 (de) * 1984-01-19 1994-09-15 Hoffmann La Roche Imidazodiazepin-derivate.
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
DK443589D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK41191D0 (da) * 1991-03-07 1991-03-07 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
FI922827A0 (fi) 1992-06-17
CZ185092A3 (en) 1993-12-15
IS3878A (is) 1992-12-18
FI922827A7 (fi) 1992-12-18
NZ243091A (en) 1994-11-25
IE921945A1 (en) 1992-12-30
NO922367L (no) 1992-12-18
KR930000517A (ko) 1993-01-15
EP0519307A2 (de) 1992-12-23
EP0519307A3 (en) 1993-04-21
AU1823492A (en) 1992-12-24
JPH078869B2 (ja) 1995-02-01
NO922367D0 (no) 1992-06-16
US5387585A (en) 1995-02-07
JPH05202051A (ja) 1993-08-10
AU655472B2 (en) 1994-12-22
CA2069382A1 (en) 1992-12-18
HU9201929D0 (en) 1992-08-28
IL102175A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
TW201311B (cg-RX-API-DMAC7.html)
AU2004290643B2 (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines with PDE-5 inhibiting activity
Tully et al. 2-(Oxadiazolyl)-and 2-(thiazolyl) imidazo [1, 2-a] pyrimidines as agonists and inverse agonists at benzodiazepine receptors
RU2562066C2 (ru) Производные n-(имидазопиримидин-7-ил)-гетероариламидов и их применение в качестве ингибиторов pde10a
JP5147731B2 (ja) Hcvns5b阻害剤
AU2008273017B2 (en) Heterocyclic compounds useful as Raf kinase inhibitors
CA2284737C (en) [1,2,4]triazolo[1,5-c]pyrimidine derivatives
AU2007260851B2 (en) Purinone derivatives as HM74a agonists
AU2011252116B2 (en) Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
KR102732404B1 (ko) 파르네소이드 x 수용체 조정제로서의 알켄 화합물
CA2706990A1 (en) Isoxazolo-pyrazine derivatives
AU2008293845B2 (en) Compounds for the treatment of hepatitis C
JP2018527353A (ja) フェノキシメチル誘導体
CA2707821A1 (en) Isoxazolo-pyridazine derivatives
MC1640A1 (fr) Derives de l'imidazodiazepine
JP2014513071A (ja) ウィント経路遮断薬
KR102732405B1 (ko) 파르네소이드 x 수용체 조정제로서의 알켄 스피로시클릭 화합물
TW460469B (en) Tricyclic 5,6-dihydro-9H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridines
FR3072679A1 (fr) Nouveaux derives macrocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN119013030A (zh) Cdk4/6激酶的抑制剂
CN115461338B (zh) 具有kdm5抑制活性的3-氮杂二环(3.1.0)己烷衍生物及其用途
RU2685417C1 (ru) Гидроксипуриновые соединения и их применение
HK1128917B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity
HK1201257B (en) Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
HK1099286B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines with pde-5 inhibiting activity